SCHEMBL25352005

SCHEMBL25352005

FC(F)c1nnc(-c2ccc(Cn3cc(-c4ccc(CN5CC6(COC6)C5)cc4)nn3)cc2)o1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 4/20 0.56
▸ KCNH2 Q12809 3/20 0.44
▸ MCHR1 Q99705 3/20 0.44
▸ HRH3 Q9Y5N1 1/20 0.44
▸ HDAC1 Q13547 2/20 0.40
▸ HDAC3 O15379 1/20 0.40
▸ HDAC2 Q92769 1/20 0.40
▸ CYP19A1 P11511 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ EPHB4 P54760 5/20 0.39
▸ TEK Q02763 5/20 0.39
▸ KDR P35968 4/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351005 0.90 HDAC6 (0.48) HDAC6KCNH2MCHR1HRH3HDAC1
SCHEMBL25351711 0.89 HDAC6 (0.47) HDAC6KCNH2MCHR1HRH3HDAC1
SCHEMBL24216754 0.85 HDAC6 (0.61) HDAC6HDAC1HDAC3HDAC2CYP19A1
SCHEMBL25351712 0.85 HDAC6 (0.61) HDAC6KCNH2MCHR1HRH3HDAC1
SCHEMBL25350175 0.83 HDAC6 (0.61) HDAC6HDAC1HDAC3HDAC2CYP19A1
SCHEMBL24215835 0.82 HDAC6 (0.62) HDAC6CYP19A1NPC1RAB9AMEN1
SCHEMBL22558008 0.82 HDAC6 (0.62) HDAC6CYP19A1NPC1RAB9AMEN1
SCHEMBL25351764 0.82 HDAC6 (0.61) HDAC6KCNH2MCHR1HDAC1HDAC3
SCHEMBL25350768 0.82 HDAC6 (0.61) HDAC6HDAC1HDAC3HDAC2CYP19A1
SCHEMBL24599266 0.81 HDAC6 (0.61) HDAC6CYP19A1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230257372-A1 NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME HDAC6, HDAC1, HDAC3 HDAC6 1/4885KCNH2 4564/4885MCHR1 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback